Skip to search.
 FTSE 100 Up 0.77%

More On AUXL

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Auxilium Pharmaceuticals Inc. (AUXL)

-NasdaqGS
0.00 0.00(0.00%) N/A
Add to Portfolio
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:32.65
Beta:-0.29
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:17.10 - 37.92
Volume:0
Avg Vol (3m):N/A
Market Cap:0.00
P/E (ttm):N/A
EPS (ttm):-2.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in .

Comparison

Symbol% ChgMkt Cap
AUXL 0.00%0.00
ABTUp 0.49%75.84b
ACT 0.00%117.33b
LLYUp 1.82%90.74b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

As of January 29, 2015, Auxilium Pharmaceuticals Inc. was acquired by Endo International plc. Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical products for u... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback